ReSuture

Executive Summary

ReSuture is a San Francisco-based medical device company developing high-fidelity, procedure-specific vascular simulations for surgical training and evaluation. Founded in 2019, the company's platform creates lifelike artificial vasculature with customizable disease states, offering a realistic alternative to cadaver and animal labs. Its sensor-embedded models capture kinetic data during procedures, providing objective performance metrics for surgeons and medical device developers. By addressing the critical need for safe, repeatable, and ethical surgical practice, ReSuture aims to improve patient outcomes and accelerate device innovation.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation simulation platform70% success
• Q2 2026Strategic partnership with a top medical device company for co-development60% success
• H2 2026Series A funding round led by prominent healthcare VC80% success